Crystal structures of active Src kinase domain complexes

Journal of Molecular Biology

Volumn 353, Issue 2, 2005, Pages 222-231

  Breitenlechner, Christine B ^a   Kairies, Norman A ^a   Honold, Konrad ^b   Scheiblich, Stefan ^b   Koll, Hans ^b   Greiter, Eva ^b   Koch, Stefan ^b   Schäfer, Wolfgang ^b   Huber, Robert ^a   Engh, Richard A ^a,b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Cell signalling; Crystal structure; Drug design; Protein kinase; Src

Indexed keywords

ADENOSINE TRIPHOSPHATE; CGP 77675; DIMER; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PURVALANOL;

ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CRYSTAL STRUCTURE; ENZYME INACTIVATION; HYDROGEN BOND; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

EID: 25144523329     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.08.023     Document Type: Article

References (49)

1. T. Hunter, and B.M. Sefton Transforming gene product of Rous sarcoma virus phosphorylates tyrosine Proc. Natl Acad. Sci. USA 77 1980 1311 1315
2. A.P. Czernilofsky, A.D. Levinson, H.E. Varmus, J.M. Bishop, E. Tischer, and H.M. Goodman Nucleotide sequence of an avian sarcoma wirus oncogene (Src) and proposed amino acid sequence for gene product Nature 287 1980 198 203
3. D.E. Schwartz, R. Tizard, and W. Gilbert Nucleotide sequence of Rous sarcoma virus Cell 32 1983 853 869
4. S.V. Russello, and S.K. Shore SRC in human carcinogenesis Front. Biosci. 8 2003 S1068 S1073
5. M.C. Frame Src in cancer: deregulation and consequences for cell behaviour Biochim. Biophys. Acta Rev. Cancer 1602 2002 114 130
6. C.A. Cartwright, M.P. Kamps, A.I. Meisler, J.M. Pipas, and W. Eckhart Pp60c-Src activation in human colon carcinoma J. Clin. Invest. 83 1989 2025 2033
7. J.B. Bolen, A. Veillette, A.M. Schwartz, V. Deseau, and N. Rosen Activation of pp60c-Src protein kinase activity in human colon carcinoma Proc. Natl Acad. Sci. USA 84 1987 2251 2255
8. T.J. Yeatman A renaissance for SRC Nature Rev. Cancer 4 2004 470 480
9. G. Manning, D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam The protein kinase complement of the human genome Science 298 2002 1912 1934
10. H. Yamaguchi, and W.A. Hendrickson Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation Nature 384 1996 484 489
11. X.T. Zhu, J.L. Kim, J.R. Newcomb, P.E. Rose, D.R. Stover, and L.M. Toledo Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors Struct. Fold. Des. 7 1999 651 661
12. W.Q. Xu, S.C. Harrison, and M.J. Eck Three-dimensional structure of the tyrosine kinase c-Src Nature 385 1997 595 602
13. W.Q. Xu, A. Doshi, M. Lei, M.J. Eck, and S.C. Harrison Crystal structures of c-Src reveal features of its autoinhibitory mechanism Mol. Cell. 3 1999 629 638
14. J.C. Williams, A. Weijland, S. Gonfloni, A. Thompson, S.A. Courtneidge, G. Superti-Furga, and R.K. Wierenga The 2.35 Å crystal structure of the inactivated form of chicken src: a dynamic molecule with multiple regulatory interactions J. Mol. Biol. 274 1997 757 775
15. F. Sicheri, I. Moarefi, and J. Kuriyan Crystal structure of the Src family tyrosine kinase Hck Nature 385 1997 602 609
16. T. Schindler, F. Sicheri, A. Pico, A. Gazit, A. Levitzki, and J. Kuriyan Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor Mol. Cell. 3 1999 639 648
17. S.C. Harrison Variation on an Src-like theme Cell 112 2003 737 740
18. M. Okada, S. Nada, Y. Yamanashi, T. Yamamoto, and H. Nakagawa CSK: a protein-tyrosine kinase involved in regulation of Src family kinases J. Biol. Chem. 266 1991 24249 24252
19. S.W. Cowan-Jacob, G. Fendrich, J. Liebetanz, D. Fabbro, and P.W. Manley 226th ACS National Meeting 2003 American Chemical Society New York
20. T.J. Boggon, and M.J. Eck Structure and regulation of Src family kinases Oncogene 23 2004 7918 7927
21. A. Ogawa, Y. Takayama, H. Sakai, K.T. Chong, S. Takeuchi, and A. Nakagawa Structure of the carboxyl-terminal Src kinase, Csk J. Biol. Chem. 277 2002 14351 14354
22. M. Lamers, A.A. Antson, R.E. Hubbard, R.K. Scott, and D.H. Williams Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine J. Mol. Biol. 285 1999 713 725
23. B. Nagar, W.G. Bornmann, P. Pellicena, T. Schindler, D.R. Veach, and W.T. Miller Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571) Cancer Res. 62 2002 4236 4243
24. B. Nagar, O. Hantschel, M.A. Young, K. Scheffzek, D. Veach, and V. Bornmann Structural basis for the autoinhibition of c-Abl tyrosine kinase Cell 112 2003 859 871
25. T. Schindler, W. Bornmann, P. Pellicena, W.T. Miller, B. Clarkson, and J. Kuriyan Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase Science 289 2000 1938 1942
26. S. Cox, E. Radzioandzelm, and S.S. Taylor Domain movements in protein kinases Curr. Opin. Struct. Biol. 4 1994 893 901
27. R.A. Engh, and D. Bossemeyer The protein kinase activity modulation sites: mechanisms for cellular regulation - targets for therapeutic intervention Advan. Enzyme Regul. 41 2001 121 149
28. B. Nolen, S. Taylor, and G. Ghosh Regulation of protein kinases: controlling activity through activation segment conformation Mol. Cell. 15 2004 661 675
29. S.W. Cowan-Jacob, G. Fendrich, P.W. Manley, W. Jahnke, D. Fabbro, J. Liebetanz, and T. Meyer The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation Structure 13 2005 861 871
30. S. Gonfloni, F. Frischknecht, M. Way, and G. Superti-Furga Leucine 255 of Src couples intramolecular interactions to inhibition of catalysis Nature Struct. Biol. 6 1999 760 764
31. M. LaFevre-Bernt, F. Sicheri, A. Pico, M. Porter, J. Kuriyano, and W.T. Miller Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue J. Biol. Chem. 273 1998 32129 32134
32. S.R. Hubbard, L. Wei, L. Elis, and W.A. Hendrickson Crystal structure of the tyrosine kinase domain of the human insulin receptor Nature 372 1994 746 754
33. S.R. Hubbard Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog EMBO J. 16 1997 5572 5581
34. J. Nowakowski, C.N. Cronin, D.E. McRee, M.W. Knuth, C.G. Nelson, and N.P. Pavletich Structures of the cancer-related aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography Structure 10 2002 1659 1667
35. M.A. Young, S. Gonfloni, G. Superti-Furga, B. Roux, and J. Kuriyan Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation Cell 105 2001 115 126
36. M. Missbach Preparation of 4-aminopyrrolo[2,3-d]pyrimidines as inhibitors of the protein tyrosine kinase pp60c-src WO 9610028 1996 Ciba-Geigy AG Switzerland
37. M. Missbach, M. Jeschke, J. Feyen, K. Muller, M. Glatt, J. Green, and M. Susa A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo Bone 24 1999 437 449
38. Y. Liu, A. Bishop, L. Witucki, B. Kraybill, E. Shimizu, and J. Tsien Structural basis for selective inhibition of Src family kinases by PP1 J. Biol. Chem. 6 1999 671 678
39. J. Bain, H. McLauchlan, M. Elliott, and P. Cohen The specificities of protein kinase inhibitors: an update Biochem. J. 371 2003 199 204
40. M. Knockaert, and L. Meijer Identifying in vivo targets of cyclin-dependent kinase inhibitors by affinity chromatography Biochem. Pharm. 64 2002 819 825
41. M. Knockaert, N. Gray, E. Damiens, Y.T. Chang, P. Grellier, and K. Grant Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors Chem. Biol. 7 2000 411 422
42. N. Villerbu, A.M. Gaben, G. Redeuilh, and J. Mester Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities Int. J. Cancer 97 2002 761 769
43. N.S. Gray, L. Wodicka, A. Thunnissen, T.C. Norman, S.J. Kwon, and F.H. Espinoza Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors Science 281 1998 533 538
44. H.L. De Bondt, J. Rosenblatt, J. Jancarik, H.D. Jones, D.O. Morgan, and S.H. Kim Crystal structure of cyclin-dependent kinase 2 Nature 363 1993 595 602
45. P.D. Jeffrey, A.A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massague, and N.P. Pavletich Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex (see comments) Nature 376 1995 313 320
46. N.R. Brown, M.E. Noble, A.M. Lawrie, M.C. Morris, P. Tunnah, and G. Divita Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity J. Biol. Chem. 274 1999 8746 8756
47. M. Missbach, E. Altmann, L. Widler, M. Susa, E. Buchdunger, and H. Mett Substituted 5,7-diphenyl-pyrrolo 2,3d pyrimidines: potent inhibitors of the tyrosine kinase c-Src Bioorg. Med. Chem. Letters 10 2000 945 949
48. G.N. Murshudov, A.A. Vagin, and E.J. Dodson Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallog. sect. D 53 1997 240 255
49. P.R. Gerber, and K. Muller MAB, a generally applicable molecular-force field for structure modeling in medicinal chemistry J. Comp. Mol. Des. 9 1995 251 268